Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure

Details for Australian Patent Application No. 2005226906 (hide)

Owner Boehringer Ingelheim Vetmedica GmbH

Inventors Kleemann, Rainer; Jons, Olaf; Daemmgen, Juergen

Agent Davies Collison Cave

Pub. Number AU-B-2005226906

PCT Pub. Number WO2005/092343

Priority 04007179.7 25.03.04 EP

Filing date 19 March 2005

Wipo publication date 6 October 2005

Acceptance publication date 23 December 2010

International Classifications

A61K 31/444 (2006.01)

A61K 31/4166 (2006.01)

A61K 31/4412 (2006.01) - having oxo groups directly attached to the heterocyclic ring

A61K 31/4427 (2006.01) - containing further heterocyclic ring systems

A61K 31/501 (2006.01) - not condensed and containing further heterocyclic rings

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

12 October 2006 PCT application entered the National Phase

  PCT publication WO2005/092343 Priority application(s): WO2005/092343

23 December 2010 Application Accepted

  Published as AU-B-2005226906

21 April 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005226909-Disintegrating tablets comprising licarbazepine

2005226901-Use of N- (2-aryl-propionyl)-sulfonamides for the treatment of spinal cord injury